SLC7A11 and pancreatic adenocarcinoma: SLC7A11 is often aberrantly expressed in multiple cancer types, including pancreatic adenocarcinoma (PAAD) which implies that the regulation of tumor cell growth may be accomplished through the upregulation of SLC7A11 to cause disulfide death [7].